CAN-FITE BIOPHARMA LTD's ticker is CANF and the CUSIP is 13471N102. A total of 9 filers reported holding CAN-FITE BIOPHARMA LTD in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,000 | – | 200 | +189.9% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 69 | -84.9% | 0.00% | – |
| Q2 2015 | $1,000 | -50.0% | 458 | -34.2% | 0.00% | – |
| Q1 2015 | $2,000 | -60.0% | 696 | -53.6% | 0.00% | – |
| Q4 2014 | $5,000 | -28.6% | 1,500 | +32.3% | 0.00% | -100.0% |
| Q4 2013 | $7,000 | – | 1,134 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TAYLOR ASSET MANAGEMENT INC | 348,500 | $763,000 | 0.14% |
| MENTA CAPITAL LLC | 12,200 | $27,000 | 0.00% |
| Virtu KCG Holdings LLC | 22,042 | $48,000 | 0.00% |
| MSI Financial Services Inc | 2,000 | $4,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 458 | $1,000 | 0.00% |
| UBS Group AG | 5,194 | $11,000 | 0.00% |
| CITIGROUP INC | 17 | $0 | 0.00% |